MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-10-2023
Syneos Health Depreciation & Amortization 2011-2026 | SYNH
Annual Depreciation & Amortization Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 236 M | 222 M | 242 M | 274 M | 180 M | 59.2 M | 56 M | 54.5 M | 58.5 M | 78.8 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 274 M | 54.5 M | 146 M |
Quarterly Depreciation & Amortization Syneos Health
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.6 M | - | - | - | 62.2 M | - | 17.7 M | 18.2 M | 57.9 M | - | 168 M | 112 M | 56.1 M | - | 182 M | 122 M | 61.2 M | - | 204 M | 136 M | 68 M | - | 96.6 M | 31.2 M | 15.6 M | - | 43.6 M | 14.5 M | 14.4 M | - | 13.8 M | 13.9 M | 14.2 M | - | 14.3 M | 11.3 M | 14.4 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 204 M | 11.3 M | 62.4 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
CareDx, Inc
CDNA
|
15 M | $ 17.82 | - | $ 950 M |  USA |
 |
Agilent Technologies
A
|
321 M | $ 114.84 | - | $ 34.9 B | USA |
 |
Co-Diagnostics
CODX
|
1.11 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 168.22 | - | $ 8.34 B | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 24.73 | - | $ 687 M | USA |
 |
Danaher Corporation
DHR
|
750 M | $ 192.12 | - | $ 137 B | USA |
 |
DexCom
DXCM
|
252 M | $ 63.21 | - | $ 24.7 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 16.42 | -2.38 % | $ 496 M | USA |
 |
Guardant Health
GH
|
39.7 M | $ 89.66 | - | $ 11.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 109.62 | - | $ 9.04 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.97 | - | $ 8.72 M | USA |
 |
Illumina
ILMN
|
354 M | $ 127.74 | - | $ 20.3 B | USA |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 274.46 | - | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 75.89 | - | $ 5.12 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 16.3 | - | $ 175 M |  China |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 496.0 | - | $ 14.3 B | USA |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 4.67 | - | $ 432 M | USA |
 |
ENDRA Life Sciences
NDRA
|
44 K | $ 4.74 | 1.07 % | $ 3.73 M | USA |
 |
NeoGenomics
NEO
|
36.1 M | $ 8.02 | - | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.56 | - | $ 2.07 B | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 17.33 | - | $ 388 M | USA |
 |
Natera
NTRA
|
16.7 M | $ 204.87 | - | $ 20.2 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
Pacific Biosciences of California
PACB
|
13 M | $ 1.42 | - | $ 426 M | USA |
 |
Precipio
PRPO
|
1.24 M | $ 25.98 | 2.28 % | $ 41.7 M | USA |
 |
Personalis
PSNL
|
10.9 M | $ 6.58 | - | $ 390 M | USA |
 |
Sotera Health Company
SHC
|
94.9 M | $ 14.87 | - | $ 4.22 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.02 M | $ 52.25 | - | $ 2.66 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Neuronetics
STIM
|
3.46 M | $ 1.76 | - | $ 116 M | USA |
|
Biodesix
BDSX
|
5.77 M | $ 15.36 | - | $ 1.99 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.05 B | $ 488.19 | - | $ 184 B | USA |
 |
VolitionRx Limited
VNRX
|
984 K | $ 0.17 | - | $ 21.4 M |  Singapore |
 |
Waters Corporation
WAT
|
88.1 M | $ 304.09 | - | $ 18.1 B | USA |
 |
Exagen
XGN
|
2.1 M | $ 3.08 | - | $ 66.4 M | USA |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
38.3 K | $ 2.59 | - | $ 84.1 K | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
9.53 M | $ 1.15 | - | $ 6.26 M | USA |